Citation Impact
Citing Papers
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
Structure of the PAPP-ABP5 complex reveals mechanism of substrate recognition
2022 StandoutNobel
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
2017 Standout
Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action
2004
Regulation of the Voltage Gated K<sup>+</sup> Channel K<sub>v1.3</sub> by Recombinant Human Klotho Protein
2014 Standout
The Impact of Immunosuppression on Endothelial Function
2004
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients
2012 Standout
Lipopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children
2007
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Hepatocyte Growth Factor Gene Therapy and Angiotensin II Blockade Synergistically Attenuate Renal Interstitial Fibrosis in Mice
2002
Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis
2013 Standout
TGF-β: the master regulator of fibrosis
2016 Standout
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Dissection of Key Events in Tubular Epithelial to Myofibroblast Transition and Its Implications in Renal Interstitial Fibrosis
2001 Standout
Application of insulin-like growth factor-1 in the treatment of inner ear disorders
2014
“Venopathy” at work: recasting neointimal hyperplasia in a new light
2010
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery*
2013 Standout
Fracture Risk after Parathyroidectomy among Chronic Hemodialysis Patients
2007
Prevention of VTE in Nonsurgical Patients
2012 Standout
Cellular and molecular mechanisms of renal fibrosis
2011 Standout
Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease
2010 Standout
Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients
2002
Insulin glargine
2000
Cellular phenotypes in human stenotic lesions from haemodialysis vascular access
2009
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Intensification of Antiretroviral Therapy With Raltegravir or Addition of Hyperimmune Bovine Colostrum in HIV-Infected Patients With Suboptimal CD4+ T-Cell Response: A Randomized Controlled Trial
2011
Calcium Balance during Hemodialysis
2007
Increased Venous Proinflammatory Gene Expression and Intimal Hyperplasia in an Aorto-Caval Fistula Model in the Rat
2003
The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway
2005 Standout
Role of Intrarenal Endothelin 1, Endothelin 3, and Angiotensin II Expression in Chronic Cyclosporin A Nephrotoxicity in Rats
2000
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Hemodialysis Vascular Access Dysfunction
2006
Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family
2001 StandoutNobel
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Survival following parathyroidectomy among United States dialysis patients
2004
Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases
2001
Pharmacology of Insulin Detemir
2007
Review of dialysate calcium concentration in hemodialysis
2006
Advances and New Frontiers in the Pathophysiology of Venous Neointimal Hyperplasia and Dialysis Access Stenosis
2009
Met, metastasis, motility and more
2003 Standout
The Physiology of Glucagon-like Peptide 1
2007 Standout
Insulin detemir: from concept to clinical experience
2006
Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes
2009
Glucagon-Like Peptide-1 Synthetic Analogs: New Therapeutic Agents for Use in the Treatment of Diabetes Mellitus
2003
Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism
2005
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
2008 Standout
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
2011 Standout
Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways
2000
Fibroblasts in cancer
2006 Standout
Chronic Kidney Disease
2016 Standout
Vascular access in haemodialysis: strengthening the Achilles' heel
2013
A pilot study of genetic polymorphisms and hemodialysis vascular access thrombosis
2009
Hepatocyte growth factor and the kidney
2002
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Cell Biology of the Glomerular Podocyte
2003 Standout
Structure and Nanostructure in Ionic Liquids
2015 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Endothelin-A receptor blockade slows the progression of renal injury in experimental renovascular disease
2011
IGF-binding protein-5: flexible player in the IGF system and effector on its own
2002
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
1997 Standout
Prevention of insulin self-aggregation by a protic ionic liquid
2012
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
2004 Standout
Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells.
2000
Vitamin D and Immune Function
2013 Standout
40 YEARS OF IGF1: Role of IGF-binding proteins in regulating IGF responses to changes in metabolism
2018
Bone biopsy results and serum bone turnover parameters in uremic children
2000
Specific binding of proinsulin C-peptide to human cell membranes
1999
Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.
2000
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
2000
Biomarkers of Acute Kidney Injury
2007
Clinical Practice Guideline: Sudden Hearing Loss (Update)
2019 Standout
Enhanced cellular proliferation in intact stenotic lesions derived from human arteriovenous fistulas and peripheral bypass grafts. Does it correlate with flow parameters?
1996 Standout
Severely Reduced Production of Klotho in Human Chronic Renal Failure Kidney
2001
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
2020 Standout
NFAT Regulates Insulin Gene Promoter Activity in Response to Synergistic Pathways Induced by Glucose and Glucagon-Like Peptide-1
2002
Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
2012 Standout
Non‐alcoholic fatty liver disease ( NAFLD ) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes
2017
The Treat-to-Target Trial
2003 Standout
Works of Peter Jehle being referenced
Renal Osteodystrophy: New Insights in Pathophysiology and Treatment Modalities with Special Emphasis on the Insulin-Like Growth Factor System
1998
Human Insulin-Like Growth Factor I (IGF-I) Produced in the Mammary Glands of Transgenic Rabbits: Yield, Receptor Binding, Mitogenic Activity, and Effects on IGF-Binding Proteins
1997
Different Acute-Phase Response in Newborns and Infants Undergoing Surgery
2002
Evaluation of IGF System Component Levels and Mitogenic Activity of Uremic Serum on Normal Human Osteoblasts
2000
Endothelin release by rabbit proximal tubule cells: Modulatory effects of cyclosporine A, tacrolimus, HGF and EGF
1998
Effects of Reduced Dialysate Calcium on Calcium-Phosphorus Product and Bone Metabolism in Hemodialysis Patients
2004
Clinical course after total parathyroidectomy without autotransplantation in patients with end-stage renal failure
1999
Ghrelin and the enteroinsular axis in healthy men
2007
Increased expression of TGF-β1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas
2002
Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy
2000
Inhibitory Effect of Epidermal Growth Factor and Hepatocyte Growth Factor on Endothelin-1 Release by Rabbit Proximal Tubule Cells
2000
Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens
1999
Serum levels of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-1 to -6 and their relationship to bone metabolism in osteoporosis patients
2003
Hepatocyte growth factor in renal failure: Promise and reality
2000
Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy
2000
Prevalence of elevated liver enzymes in adults with type 1 diabetes: A multicentre analysis of the G erman/ A ustrian DPV database
2017
Enteral application of an immunoglobulin-enriched colostrum milk preparation for reducing endotoxin translocation and acute phase response in patients undergoing coronary bypass surgery--a randomized placebo-controlled pilot trial.
2002
Proinsulin stimulates growth of small intestinal crypt-like cells acting via specific receptors
1999
Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes
2000
Preoperative Oral Application of Immunoglobulin-Enriched Colostrum Milk and Mediator Response During Abdominal Surgery
2002
The immunosuppressive drug mycophenolic acid reduces endothelin-1 synthesis in endothelial cells and renal epithelial cells
2002